{"abstract": "The Swedish drug maker Meda said Friday that it rejected a takeover offer from the generic pharmaceutical company Mylan. A merger would have allowed Mylan to get tax benefits from being reincorporated abroad.", "web_url": "https://dealbook.nytimes.com/2014/04/04/mylan-considers-bid-for-swedish-pharmaceuticals-rival/", "snippet": "The Swedish drug maker Meda said Friday that it rejected a takeover offer from the generic pharmaceutical company Mylan. A merger would have allowed Mylan to get tax benefits from being reincorporated abroad.", "lead_paragraph": "Updated, 10:58 a.m. | LONDON \u2013 The Swedish drug maker Meda said Friday that it rejected a takeover offer from the generic pharmaceutical company Mylan.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/05/business/dbpix-drug/dbpix-drug-articleLarge.jpg", "height": 176, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/04/05/business/dbpix-drug/dbpix-drug-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 176}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/05/business/dbpix-drug/dbpix-drug-jumbo.jpg", "height": 301, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/05/business/dbpix-drug/dbpix-drug-superJumbo.jpg", "height": 602, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/05/business/dbpix-drug/dbpix-drug-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/04/05/business/dbpix-drug/dbpix-drug-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/05/business/dbpix-drug/dbpix-drug-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Meda, a Swedish Drug Maker, Rejects Takeover Offer", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Meda AB", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Mylan Inc", "rank": 5, "major": "N"}, {"name": "glocations", "value": "Sweden", "rank": 6, "major": "N"}], "pub_date": "2014-04-04T10:58:55+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray and David Gelles", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/7e3e8dc6-e842-5bde-9b49-9ba986134aa4", "word_count": 472, "uri": "nyt://article/7e3e8dc6-e842-5bde-9b49-9ba986134aa4"}